News

The Boston Globe: Work underway on nine-story lab building in Watertown

January 2021

Tim Logan of the Boston Globe covered the financing and beginning of construction for our new life sciences building, 100 Forge.

Read the full article here

Introducing 100 Forge

January 2021

100 Forge Rendering

 

Boylston Properties and J.P. Morgan Announce Joint Venture to Build 100 Forge, a 165,600-Square-Foot Life Science Building in Arsenal Yards, Watertown  

Construction of 100 Forge commenced this month, January 2021

Watertown, MA – Thursday, January 28, 2021 – Boylston Properties, a Boston-based developer of mixed-use destinations, and institutional investors advised by J.P. Morgan Asset Management, today announced a joint venture agreement to proceed with plans to construct 100 Forge, a nine-story 165,600-square-foot lab building at Arsenal Yards in Watertown.

As Boylston Properties and J.P. Morgan announce their second JV at this property,100 Forge is being revealed as the first purpose-built lab building in Watertown. With a focus on signature design, the 130-foot-tall landmark building will afford tenants with great views of the Charles River to the south and the Boston skyline to the east.

Construction began this month, January 2021, and a $100.1 million construction loan for the project from Bank OZK was arranged by JLL Capital Market’s Fred Wittmann, Brett Paulsrud and Henry Schaffer. Erland Construction is the contractor of record. Cushman and Wakefield, the region’s leading broker for premier life science real estate, is leading the process of finding the most innovative tenants to call 100 Forge home.

Read the full press release

Life Science Cluster Forms on Arsenal Street

October 2020

Our very own Bill McQuillan wrote an article that appeared in the most recent edition of Banker & Tradesman (paywall – link to full article below):

There aren’t too many things in this world right now that feel like a sure thing. Uncertainty abounds in Boston and beyond. Aside from the foremost importance of the health and safety of our families, friends and colleagues, the real estate industry in particular has felt its share of economic impact in the retail, hospitality, office, and even residential rental sectors. It’s ugly for us out there. 

Other than the prospect of an early 2021 vaccine, of which the subject of this column plays a central role in achieving, there is one tiny gleam of light breaking through the real estate darkness: Before COVID-19, the biotech industry and subsequent lab asset class in Greater Boston was red hot, and during COVID-19, that industry has demonstrated itself as ever more relevant and increasingly critical to the real estate sector in Greater Boston and the commonwealth. 

We cheer on the gains and breakthroughs these scientists and doctors make in the field of science and medicine, and you can bet we rush to support their success and growth with high-quality, class A space that enables them to achieve and solve our most complex challenges and afflictions. 

 

Read the full article from Banker & Tradesman

Common Allbright Approved by the Zoning Board of Appeal (ZBA)

October 2020

Boylston Properties is pleased to announce that Common Allbright, an 80 unit coliving concept that we hope will help solve housing availability & affordability challenges in the city and Allston in particular, was recently approved by the City of Boston’s Zoning Board of Appeal (ZBA).

For more information on this project, please read our most recent press release. 

Rendering of Common Allbright provided by HDS Architecture

Rendering of Common Allbright provided by HDS Architecture